Literature DB >> 23245439

ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections.

Pingping Ren1, Lin Zhang, Gaiping Xu, Laura C Palmero, Paul T Albini, Joseph S Coselli, Ying H Shen, Scott A LeMaire.   

Abstract

BACKGROUND: ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) is a recently identified family of extracellular metalloproteinases that has been shown to participate in tissue destruction. We hypothesized that ADAMTS-1 and ADAMTS-4 expression is increased in aortic tissues from patients with thoracic aortic aneurysms and dissections.
METHODS: We examined ADAMTS-1 and ADAMTS-4 expression in human descending thoracic aortic aneurysms (n = 14), chronic descending thoracic aortic dissections (n = 16), and descending thoracic aortas from age-matched control organ donors (n = 12). In these tissues, we also evaluated the degradation of versican, a proteoglycan substrate of ADAMTS-1 and ADAMTS-4. In cultured macrophages, we examined whether ADAMTS-4 functions in macrophage infiltration by using a transwell assay.
RESULTS: ADAMTS-1 and ADAMTS-4 protein and mRNA expression was significantly higher in thoracic aortic aneurysm and dissection tissues than in control aortic tissues. Double immunofluorescence staining showed the expression of ADAMTS-1 and ADAMTS-4 in smooth muscle cells and macrophages. Consistent with the upregulation of ADAMTS-1 and ADAMTS-4 in thoracic aortic aneurysm and dissection tissues, versican was degraded significantly more in these tissues than in control aortic tissues. In cultured macrophages, transforming growth factor-β increased ADAMTS-4 protein levels and induced macrophage invasion, and the knockdown of ADAMTS-4 reduced cell invasion.
CONCLUSIONS: Increased expression of ADAMTS proteins may promote thoracic aortic aneurysm progression by degrading versican and facilitating macrophage invasion.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245439      PMCID: PMC3593585          DOI: 10.1016/j.athoracsur.2012.10.084

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  35 in total

1.  Versican V0 and V1 guide migratory neural crest cells.

Authors:  Shilpee Dutt; Maurice Kléber; Mattia Matasci; Lukas Sommer; Dieter R Zimmermann
Journal:  J Biol Chem       Date:  2006-03-01       Impact factor: 5.157

2.  Hyaluronate binding properties of versican.

Authors:  R G LeBaron; D R Zimmermann; E Ruoslahti
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

Review 3.  Aortic aneurysm formation: lessons from human studies and experimental models.

Authors:  M J Davies
Journal:  Circulation       Date:  1998-07-21       Impact factor: 29.690

4.  Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury.

Authors:  Mervyn J Merrilees; Joan M Lemire; Jens W Fischer; Michael G Kinsella; Kathleen R Braun; Alexander W Clowes; Thomas N Wight
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

Review 5.  Versican degradation and vascular disease.

Authors:  Richard D Kenagy; Anna H Plaas; Thomas N Wight
Journal:  Trends Cardiovasc Med       Date:  2006-08       Impact factor: 6.677

6.  Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome.

Authors:  L Pulkkinen; K Kainulainen; T Krusius; P Mäkinen; J Schollin; K H Gustavsson; L Peltonen
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

7.  ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165.

Authors:  Alfonso Luque; Darren R Carpizo; M Luisa Iruela-Arispe
Journal:  J Biol Chem       Date:  2003-04-25       Impact factor: 5.157

Review 8.  Inflammation and cellular immune responses in abdominal aortic aneurysms.

Authors:  Koichi Shimizu; Richard N Mitchell; Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-23       Impact factor: 8.311

9.  Versican undergoes specific alterations in the fine molecular structure and organization in human aneurysmal abdominal aortas.

Authors:  A D Theocharis; I Tsolakis; A Hjerpe; N K Karamanos
Journal:  Biomed Chromatogr       Date:  2003-09       Impact factor: 1.902

10.  The ability of versican to simultaneously cause apoptotic resistance and sensitivity.

Authors:  David P LaPierre; Daniel Y Lee; Sen-Zhu Li; Yi-Zhen Xie; Ling Zhong; Wang Sheng; Zhaoqun Deng; Burton B Yang
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

View more
  38 in total

Review 1.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

2.  Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome.

Authors:  Jorge Oller; Nerea Méndez-Barbero; E Josue Ruiz; Silvia Villahoz; Marjolijn Renard; Lizet I Canelas; Ana M Briones; Rut Alberca; Noelia Lozano-Vidal; María A Hurlé; Dianna Milewicz; Arturo Evangelista; Mercedes Salaices; J Francisco Nistal; Luis Jesús Jiménez-Borreguero; Julie De Backer; Miguel R Campanero; Juan Miguel Redondo
Journal:  Nat Med       Date:  2017-01-09       Impact factor: 53.440

Review 3.  Molecular mechanisms of thoracic aortic dissection.

Authors:  Darrell Wu; Ying H Shen; Ludivine Russell; Joseph S Coselli; Scott A LeMaire
Journal:  J Surg Res       Date:  2013-06-29       Impact factor: 2.192

Review 4.  Review of molecular and mechanical interactions in the aortic valve and aorta: implications for the shared pathogenesis of aortic valve disease and aortopathy.

Authors:  Varun K Krishnamurthy; Richard C Godby; G R Liu; J Michael Smith; Loren F Hiratzka; Daria A Narmoneva; Robert B Hinton
Journal:  J Cardiovasc Transl Res       Date:  2014-11-20       Impact factor: 4.132

5.  C/EBPβ and Nuclear Factor of Activated T Cells Differentially Regulate Adamts-1 Induction by Stimuli Associated with Vascular Remodeling.

Authors:  Jorge Oller; Arántzazu Alfranca; Nerea Méndez-Barbero; Silvia Villahoz; Noelia Lozano-Vidal; Mara Martín-Alonso; Alicia G Arroyo; Amelia Escolano; Angel Luis Armesilla; Miguel R Campanero; Juan Miguel Redondo
Journal:  Mol Cell Biol       Date:  2015-07-27       Impact factor: 4.272

6.  From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases.

Authors:  Raffaele Serra; Luca Gallelli; Lucia Butrico; Gianluca Buffone; Francesco G Caliò; Giovanni De Caridi; Mafalda Massara; Andrea Barbetta; Bruno Amato; Miriam Labonia; Selena Mimmi; Enrico Iaccino; Stefano de Franciscis
Journal:  Int Wound J       Date:  2016-03-15       Impact factor: 3.315

Review 7.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

8.  HtrA1 upregulates the expression of ADAMTS-5 in HNPCs via the ERK/NF-κB/JNK signaling pathway.

Authors:  Dapeng Li; Yumin Wu; Yan Wu; Chenlie Ni; Pan Jiang; Jian Li; Lianghao Mao; Qiping Zheng; Jiawei Yue
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 9.  Non-syndromic thoracic aortic aneurysm: cellular and molecular insights.

Authors:  Ariadna Martin-Blazquez; Angeles Heredero; Gonzalo Aldamiz-Echevarria; Marta Martin-Lorenzo; Gloria Alvarez-Llamas
Journal:  J Pathol       Date:  2021-05-24       Impact factor: 7.996

Review 10.  Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm.

Authors:  Bo Liu; David J Granville; Jonathan Golledge; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.